2026 NPPES data Optometrist NPI 1730142167 O.D.
Verify on CMS →

JOSEPH SCHNORBUS, O.D.

Optometrist in TALLADEGA, Alabama. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
916
Medicare Part D claims · 272 beneficiaries · Optometrist avg: 257
Generic prescribing
50%
generic claims · 50% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
95.6421/100
▲ 13 pts above national avg 83.1 · [object Object]

What the federal data shows

JOSEPH SCHNORBUS, O.D. reported a CMS MIPS final score of 95.6421/100 — above the 83.1 national average — and filed 916 Medicare Part D claims in 2023.

95.6421/100
MIPS score · +13 vs avg
916
Part D claims, 2023
50%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOSEPH SCHNORBUS, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

96 Top 21% higher than 79% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about JOSEPH SCHNORBUS, O.D.?

High performer (top quartile)

NPI registry status

Active

Issued 04/07/2006

NPI 1730142167

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

916 256% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

95.6421/100 12.542100000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Alabama

How Optometrist compares to other specialties among Alabama providers

Alabama providers

Optometrist share within Alabama

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Alabama

Medicare quality performance — MIPS

JOSEPH SCHNORBUS, O.D.'s 2023 MIPS final score plotted against the Optometrist national average

High performer (top quartile)
MIPS Final Score
95.6421/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 95.6421/100 vs national avg 83.1

0%100%National avg83%95.6%
MIPS final score (Optometrist) — 95.6421/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOSEPH SCHNORBUS, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 109 COOSA STREET EAST, TALLADEGA, AL, 35160, with a listed phone of (256) 362-4872. NPI 1730142167 was issued on 04/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SCHNORBUS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 916 prescription claims written by this provider, covering 272 Medicare beneficiaries and totaling roughly $178K in drug spend, split 50% brand-name and 50% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.6421/100 for the 2023 performance year (Quality 89.3802), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

109 COOSA STREET EAST
TALLADEGA, AL 35160

Provider Details

NPI 1730142167
Specialty Optometrist
Credentials O.D.
Gender Male
NPI Issued 04/07/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

95.6421
Final Score
Avg: 83.1
89.3802
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where JOSEPH SCHNORBUS, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ALABAMA EYE CLINIC PC
TALLADEGA, AL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Brand-heavy

JOSEPH SCHNORBUS, O.D. — brand share 50.0%
Specialty average (est.)

50% brand-name claims vs 50% generic, on 916 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

916
Total Claims
$178K
Total Drug Cost
272
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,906
Total Day Supply
55,038
Brand vs Generic
50% brand / 50% generic
Brand Drug Cost
$151K
Generic Drug Cost
$27K

Patient Demographics

Average Patient Age
71.3 years
Avg HCC Risk Score
1.37
Gender Split
61% female / 39% male
Age Distribution
<65: 48, 65-74: 117, 75-84: 81, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JOSEPH SCHNORBUS, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
359
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
188
Prednisolone Acetate
60
Vyzulta
Latanoprostene Bunod
33
Restasis
Cyclosporine
30
Lumigan
Bimatoprost
25
Timolol Maleate
25
Brimonidine Tartrate-Timolol
Brimonidine Tartrate/Timolol
18
Travoprost
18
Xiidra
Lifitegrast
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How JOSEPH SCHNORBUS, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

JOSEPH SCHNORBUS, O.D.'s 916 claims are above the specialty average of 257.

Nearby Optometrist Providers in Alabama

Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as SCHNORBUS.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOSEPH SCHNORBUS, O.D.'s specialty?
JOSEPH SCHNORBUS, O.D. specializes in Optometrist and practices in TALLADEGA, Alabama. Credentials: O.D..
How much does JOSEPH SCHNORBUS, O.D. prescribe under Medicare Part D?
In 2023, JOSEPH SCHNORBUS, O.D. wrote 916 Medicare Part D claims totaling $178K in drug costs for 272 beneficiaries.
What is JOSEPH SCHNORBUS, O.D.'s Medicare quality score?
JOSEPH SCHNORBUS, O.D. has a CMS MIPS Final Score of 95.6421/100 (Quality: 89.3802). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JOSEPH SCHNORBUS, O.D. located?
JOSEPH SCHNORBUS, O.D. is located at 109 COOSA STREET EAST, TALLADEGA, AL, 35160. Phone: (256) 362-4872.
What is JOSEPH SCHNORBUS, O.D.'s NPI number?
JOSEPH SCHNORBUS, O.D.'s National Provider Identifier (NPI) is 1730142167, issued on 04/07/2006.
Does JOSEPH SCHNORBUS, O.D. prescribe more brand-name or generic drugs?
JOSEPH SCHNORBUS, O.D.'s prescribing is 50% brand-name and 50% generic drugs by claim count, with $151K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does JOSEPH SCHNORBUS, O.D. prescribe most often?
Based on 2023 Medicare Part D data, JOSEPH SCHNORBUS, O.D.'s most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOSEPH SCHNORBUS, O.D. accept Medicare?
JOSEPH SCHNORBUS, O.D. appears in CMS Medicare data with 916 Part D claims and 272 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOSEPH SCHNORBUS, O.D.'s credentials?
JOSEPH SCHNORBUS, O.D.'s NPI is 1730142167 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology